Sweet Home Senior Living

Inspection Reports Summary An editor-reviewed summary of the themes and findings across this facility's recent inspection reports.

• Sweet Home Senior Living 2, a 6‑bed, 740‑type facility in Van Nuys, underwent three required annual unannounced inspections between 2021 and 2023. The 2021 visit uncovered a compliance lapse under Title 22 §87705(f)(2): over‑the‑counter medications, disinfectants, and personal hygiene items were accessible to residents with dementia. The administrator promptly locked these items and instituted a plan of correction, which the licensing evaluators accepted. That same inspection highlighted minor infection‑control oversights—staff failed to apply a face covering upon entry and did not enforce visitor temperature checks. Recommendations were issued to reinforce PPE use and visitor screening protocols. In the 2022 visit, the facility demonstrated full compliance with infection‑control standards. The licensing program analyst noted adequate PPE supplies, effective cleaning protocols, and a functional isolation plan, even though no COVID‑19 cases had occurred. Facility infrastructure—kitchen, common areas, bedrooms, restrooms, and fire safety equipment—was inspected and found to meet all regulatory requirements. The analyst recorded no deficiencies and confirmed that medications and first‑aid kits were securely stored. The 2023 inspection repeated the favorable findings of the previous year. The facility’s physical plant remained well maintained, with locked kitchen drawers, adequate hot‑water temperature, and properly serviced fire and carbon‑monoxide detectors. Restrooms and common areas continued to meet cleanliness and safety standards, and the single‑story layout provided adequate lighting and night‑light provisions. No new deficiencies were recorded, and the licensing evaluators reaffirmed that the facility’s procedures adhered to Title 22 regulations. Across the three annual reviews, Sweet Home Senior Living 2’s pattern of compliance shifted from an initial corrective action in 2021 to consistently meeting all evaluated standards in 2022 and 2023. The facility’s small capacity and limited resident census have not impeded its ability to maintain a safe environment, secure medication storage, and robust infection‑control practices. The licensing team’s documentation confirms that the administrator has taken timely corrective measures when required and that the facility continues to operate in adherence to state regulations.